Yelin Lapidot Holdings Management Ltd. Arvinas, Inc. Transaction History
Yelin Lapidot Holdings Management Ltd.
- $518 Billion
- Q1 2025
A detailed history of Yelin Lapidot Holdings Management Ltd. transactions in Arvinas, Inc. stock. As of the latest transaction made, Yelin Lapidot Holdings Management Ltd. holds 46,665 shares of ARVN stock, worth $322,921. This represents 0.06% of its overall portfolio holdings.
Number of Shares
46,665
Previous 46,873
0.44%
Holding current value
$322,921
Previous $899 Million
63.54%
% of portfolio
0.06%
Previous 0.16%
Shares
3 transactions
Others Institutions Holding ARVN
# of Institutions
245Shares Held
62.5MCall Options Held
2.65MPut Options Held
1.1M-
Vanguard Group Inc Valley Forge, PA8.36MShares$57.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$43.3 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.88MShares$26.8 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.83MShares$26.5 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$23.1 Million0.38% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $368M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...